Entrada Therapeutics, Inc.TRDANASDAQ
LOADING
|||
Operating Income Scaling
Trending higher, above historical average.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$47.01M
↑ 297% above average
Average (5y)
$-23.84M
Historical baseline
Range
High:$47.01M
Low:$-97.25M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $47.01M | +1586.7% |
| 2023 | $-3.16M | +96.7% |
| 2022 | $-97.25M | -90.2% |
| 2021 | $-51.13M | -91.7% |
| 2020 | $-26.67M | -125.5% |
| 2019 | $-11.82M | - |